Skip to main content

Chimera Bioengineering

South San Francisco, United States

Chimera solves the challenges of CARs with drug-responsive gene regulators, which allow us to re-program of the immune system.

$7.5M raised
Apr 2022
Grant

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Chimera Bioengineering

How much funding has Chimera Bioengineering raised?
Chimera Bioengineering has raised $7.5M in total funding. The most recent round was Grant. The last funding was announced in April 2022.
Who are Chimera Bioengineering's investors?
Chimera Bioengineering's investors include Kairos Ventures, Sand Hill Angels, Life Science Angels, The Angels' Forum, Asian Fund For Cancer Research.
Where is Chimera Bioengineering headquartered?
Chimera Bioengineering is headquartered in South San Francisco, United States.
What does Chimera Bioengineering do?
Chimera solves the challenges of CARs with drug-responsive gene regulators, which allow us to re-program of the immune system.
What stage is Chimera Bioengineering at?
Chimera Bioengineering is at the Grant stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Chimera Bioengineering — Funding & Investors." VCBacked, April 28, 2022, https://www.vcbacked.co/company/chimera-bioengineering. Accessed July 2, 2026.
APA
VCBacked. (2022). Chimera Bioengineering — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/chimera-bioengineering
Wikipedia (cite web)
{{cite web |title=Chimera Bioengineering — Funding & Investors |url=https://www.vcbacked.co/company/chimera-bioengineering |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .